Granite Investment Partners, LLC

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1542266 EL SEGUNDO, CA

Position in IONS

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$401,356

+$21,154 QoQ

Shares Held

5,345

+11.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Granite Investment Partners, LLC holds $55,186,477 across 10 Biotechnology names. IONS ranks #8 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	80,299	$13,572,136
2	LGND	Ligand Pharmaceuticals Inc	54,155	$10,812,045
3	APLS	Apellis Pharmaceuticals, Inc.	231,917	$9,330,020
4	TECH	BIO-TECHNE Corp	137,562	$7,188,990
5	KRYS	Krystal Biotech, Inc.	24,284	$6,273,042
6	VCEL	Vericel Corp	120,236	$3,867,992
7	HALO	Halozyme Therapeutics, Inc.	51,719	$3,342,598
8	IONS	Ionis Pharmaceuticals Inc This page	5,345	$401,356

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$401,356	5,345	+11.2%	Shares	Sole	2026-04-30
2025-12-31	$380,202	4,806	-82.9%	Shares	Sole	2026-02-12
2025-09-30	$1,833,918	28,033	-35.1%	Shares	Sole	2025-11-10
2025-06-30	$1,706,081	43,181	-36.9%	Shares	Sole	2025-08-13
2025-03-31	$2,064,653	68,434	-7.4%	Shares	Sole	2025-05-13
2024-12-31	$2,582,355	73,866	-13.9%	Shares	Sole	2025-02-13
2024-09-30	$3,436,867	85,793	-24.8%	Shares	Sole	2024-11-12
2024-06-30	$5,437,529	114,090	-1.8%	Shares	Sole	2024-08-12
2024-03-31	$5,034,842	116,144	-3.2%	Shares	Sole	2024-05-13
2023-12-31	$6,068,068	119,946	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.